Scoppetta C, Bartoccioni E, David P, Flamini G, Lo Monaco M, Scuderi F, Tonali P
J Neurol. 1982;227(2):61-5. doi: 10.1007/BF00313771.
A myasthenia gravis (MG) patient who seems to have recovered can later have recurrence of myasthenic signs. Clearly clinical remission does not always correspond to the normalization of all the factors involved in the pathogenesis of the disease. In ten patients who had apparently recovered from MG, electromyographic tests of repetitive supramaximal stimulation were performed and the anti-acetylcholine receptor (anti-AChR) antibody was assessed. In two of the ten patients all these tests were normal, thus showing lack of electromyographic myasthenic fatigability and the absence of circulating anti-AChR antibodies. Our hypothesis is that for these two subjects the risk of a recurrence of MG is lower than for the others.
一名看似已康复的重症肌无力(MG)患者,日后可能会再次出现肌无力症状。显然,临床缓解并不总是意味着参与该疾病发病机制的所有因素都恢复正常。对10名看似已从重症肌无力康复的患者进行了重复超强刺激的肌电图测试,并评估了抗乙酰胆碱受体(抗AChR)抗体。在这10名患者中,有2名患者所有这些测试结果均正常,因此显示不存在肌电图肌无力疲劳现象,且没有循环抗AChR抗体。我们的假设是,对于这两名患者,重症肌无力复发的风险低于其他患者。